MCW Alpha/Beta T-Cell and B-Cell Depletion With Targeted ATG Dosing
NCT:NCT05794880 · RECRUITING
广告
NCT编号NCT05794880
状态RECRUITING
开始日期2023-05-01
SponsorMedical College of Wisconsin (OTHER)
First posted
Last updated
简要摘要
This is a single arm pilot study for patients with hematologic malignancies receiving unrelated or haploidentical related mobilized peripheral stem cells (PSCs) using the CliniMACS system for alpha/beta T cell depletion plus CD19+ B cell depletion with individualized ALC-based dosing of ATG to study impact on engraftment, GVHD, and disease free survival
官方来源
在 ClinicalTrials.gov 上查看 →数据来自 ClinicalTrials.gov API。有关最新状态,请参阅官方记录。